Charles River Labs Q3 2023 Earnings Report
Key Takeaways
Charles River Laboratories reported a 3.8% increase in revenue to $1.03 billion for the third quarter of 2023. GAAP earnings per share decreased by 10.1% to $1.69, while non-GAAP earnings per share increased by 3.4% to $2.72. The company updated its 2023 financial guidance, narrowing its revenue growth and non-GAAP EPS ranges.
Third-quarter revenue reached $1.03 billion, a 3.8% increase year-over-year.
GAAP earnings per share decreased to $1.69, while non-GAAP earnings per share increased to $2.72.
Organic revenue growth was 4.1%, driven by the Discovery and Safety Assessment (DSA) and Research Models and Services (RMS) segments.
The company updated its 2023 financial guidance, narrowing revenue growth and non-GAAP EPS ranges.
Charles River Labs
Charles River Labs
Charles River Labs Revenue by Segment
Forward Guidance
The Company is updating its 2023 financial guidance, which was previously provided on August 9, 2023. As it moves into the fourth quarter, the Company is narrowing its revenue growth and non-GAAP earnings per share ranges. The updates principally reflect a shift in the gating of the financial results in the second half of the year, as demonstrated by the third-quarter financial performance that exceeded the Company’s prior expectations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income